Velocity Clinical Research’s Acquisition of Two Clinical Research Sites in Germany

Norton Rose Fulbright has advised Velocity Clinical Research on the deal.Velocity Clinical Research (Velocity), a portfolio company of GHO Capital (Global Healthcare Opportunities), Europe’s leading private…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Marco Zingaro

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here